Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?]Mounira El Demery, Damien Pouessel, Christophe Avancès, et al.
European Urology|February 27, 2023
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor TrialsAna Cavillon, Damien Pouessel, Nadine Houédé, et al.
Bulletin Du Cancer|October 9, 2014
[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?]Antoine Thiery-Vuillemin, Guillaume Mouillet, Damien Pouessel, et al.
European Urology|August 19, 2008
Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancerAntoine Italiano, Cécile Ortholan, Stéphane Oudard, et al.
Bulletin Du Cancer|June 23, 2022
[Metastatic renal cell carcinoma: Management of toxicities of combinations]Florence Joly, Jean-Marie Michot, Louis Marie Dourthe, et al.
European Urology|September 20, 2011
Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01)Stéphane Culine, Aude Fléchon, Aline Guillot, et al.
Oncology|July 23, 2011
5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinomaElias Assaf, Muriel Verlinde-Carvalho, Catherine Delbaldo, et al.
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.
The Oncologist|February 1, 2021
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA CohortVincent Esteyrie, Caroline Dehais, Elodie Martin, et al.
Pageof 8